Clonal deletion is the elimination of antigen-reactive lymphocytes through apoptosis, or programmed cell death. It is a mechanism of immune tolerance, particularly tolerance to the body’s own antigens. By removing potentially harmful T cells and B cells, it helps limit autoimmunity. Deletion occurs during lymphocyte development and can also affect cells outside their developmental organs. “Clonal” refers to antigen-receptor specificity: cells bearing a particular self-reactive receptor are removed from the available immune repertoire. (nature.com)
Place within immune tolerance
Adaptive immunity depends on a diverse collection of antigen receptors. Receptor diversity creates the possibility of recognizing the body’s own components as well as foreign substances. Experimental studies demonstrate that encountering an appropriate self-antigen can eliminate cells with the corresponding receptor specificity, rather than stimulate a productive immune response. This selection changes the composition of the immune system without indiscriminately destroying all lymphocytes. (nature.com)
Clonal deletion contributes to both central immune tolerance, established during development, and peripheral immune tolerance, operating beyond the primary developmental organs. It differs from clonal anergy, in which antigen-reactive cells remain present but become functionally unresponsive. In B cells, receptor editing provides another alternative: further receptor-gene rearrangement changes specificity while preserving the cell. Deletion, anergy, and editing therefore have different cellular outcomes, even when each prevents responses to the same antigen. (pubmed.ncbi.nlm.nih.gov)
T-cell deletion in the thymus
Developing T cells are screened for self-reactivity in the thymus. Their T-cell receptors recognize self-derived peptides displayed by major histocompatibility complex molecules. Strong recognition can initiate deletional negative selection. This differs from positive selection, which supports the development of cells capable of recognizing self-MHC appropriately. The outcome is not determined by receptor binding alone: developmental stage, antigen presentation, and intracellular regulatory mechanisms also affect survival. (nature.com)
Thymic deletion is not confined to one anatomical compartment. Experiments have localized antigen-induced apoptosis to the cortex, medulla, and their junction. In a mouse model involving a widely expressed self-antigen, cortical deletion was associated with dendritic cells, and removing these cells impaired deletion. Thus, describing all negative selection as an exclusively medullary process is inaccurate. (pubmed.ncbi.nlm.nih.gov)
The medulla nevertheless has a distinctive role in presenting tissue-restricted self-antigens. The autoimmune regulator protein, AIRE, promotes expression of many antigens otherwise associated with peripheral tissues in medullary thymic epithelial cells. These cells and other antigen-presenting cells cooperate in displaying self-antigens. Antigen transfer to bone-marrow-derived presenters broadens the range of autoreactive T cells subject to deletion. (pubmed.ncbi.nlm.nih.gov)
Self-antigen recognition does not invariably cause cell death. Some developing cells instead enter specialized lineages, including regulatory T cells. Consequently, deletion is one outcome of thymic tolerance induction, not a synonym for every process that prevents self-reactive conventional T cells from emerging. (nature.com)
B-cell deletion and receptor editing
Central B-cell tolerance operates in the bone marrow, where developing cells encounter self-antigens through membrane-bound immunoglobulin receptors. Classic transgenic-mouse experiments introduced antibody genes encoding recognition of an MHC class I antigen. Cells bearing that specificity were abundant when the relevant antigen was absent but were missing from peripheral populations when it was present. Bone-marrow chimera experiments further localized the tolerance checkpoint to early B-cell development. (nature.com)
Antigen form influences the outcome. In experimental systems using lysozyme as a model self-antigen, soluble antigen and highly multivalent membrane-bound antigen produced different responses, including anergy and elimination. The extent of receptor cross-linking therefore matters alongside specificity. These findings do not establish one universal rule for every self-antigen. (nature.com)
Receptor editing complicates interpretation of apparent deletion. Self-reactive immature B cells can reactivate components of the V(D)J recombination machinery and assemble new immunoglobulin light-chain genes. The original specificity may disappear even though the cell survives with a different receptor. Loss of an autoreactive receptor from a population is therefore not, by itself, proof that its original bearer died. (pubmed.ncbi.nlm.nih.gov)
Apoptotic machinery and peripheral deletion
Antigen-receptor signaling can engage intrinsic apoptotic machinery. The pro-apoptotic protein BIM is an important mediator: in mouse experiments, BIM deficiency substantially impaired deletion of autoreactive thymocytes. BIM acts within the BCL-2 protein family, linking receptor stimulation to changes in cellular survival control. The gene encoding BIM is also subject to regulatory mechanisms that influence the balance between positive selection and deletion. (nature.com)
Peripheral deletion provides an additional checkpoint. In a mouse model expressing a self-antigen in the pancreas, dendritic cells presented that antigen in draining lymph nodes through cross-presentation. Antigen-specific CD8 T cells initially proliferated but were subsequently deleted. Their elimination required BIM and was inhibited by increased BCL-2 expression. B-cell experiments likewise demonstrated deletion after antigen encounter beyond the bone marrow. (pubmed.ncbi.nlm.nih.gov)
Deletion also intersects with regulation of ongoing immune responses. Mouse studies show that BIM and the death receptor Fas can cooperate in terminating chronic responses and preventing autoimmune pathology. Such response shutdown overlaps mechanistically with tolerance, but not every death of an activated lymphocyte constitutes deletion of a self-reactive clone. (pmc.ncbi.nlm.nih.gov)
Experimental interpretation
Studies commonly compare receptor-defined cells in animals with and without the relevant antigen, measure apoptosis, or disrupt candidate survival pathways. Flow cytometry and tissue imaging help distinguish changes in population size from anatomical sites of death. Reliable interpretation requires separating actual cell loss from receptor editing, altered migration, or diversion into another lineage. Much detailed mechanistic evidence comes from genetically modified mice; these models establish particular pathways without specifying an identical deletion threshold for every human lymphocyte or self-antigen. (nature.com)